U.S., Feb. 5 -- ClinicalTrials.gov registry received information related to the study (NCT06807346) titled 'Evaluating the Efficacy of the Study Product on Overall Cognitive Function in Children' on J... Read More
U.S., Feb. 5 -- ClinicalTrials.gov registry received information related to the study (NCT06806930) titled 'Predicting Response to Neoadjuvant Endocrine Therapy (Neo-PREDICT)' on Jan. 15. Brief Summa... Read More
U.S., Feb. 5 -- ClinicalTrials.gov registry received information related to the study (NCT06806657) titled 'Safety Study in Subjects >= 12 Years of Age With Hereditary Angioedema Switching to Garadaci... Read More
U.S., Feb. 5 -- ClinicalTrials.gov registry received information related to the study (NCT06807086) titled 'Efficacy of Synchronous, Virtual Cognitive Behavioral Therapy for Insomnia Across Phases of ... Read More
U.S., Feb. 5 -- ClinicalTrials.gov registry received information related to the study (NCT06806839) titled 'Early Weight Bearing in Distal Femur Fractures' on Jan. 18. Brief Summary: Assessment of th... Read More
U.S., Feb. 5 -- ClinicalTrials.gov registry received information related to the study (NCT06806748) titled 'Gait Recovery After Stroke' on Jan. 28. Brief Summary: The purpose of this observational st... Read More
U.S., Feb. 5 -- ClinicalTrials.gov registry received information related to the study (NCT06806969) titled 'Artificial Intelligence Enabled Decision Support for Selection of Patients for Lumbar Spine ... Read More
U.S., Feb. 5 -- ClinicalTrials.gov registry received information related to the study (NCT06806410) titled 'The Efficacy of Liposomal Bupivacaine in Ultrasound Guided Supraclavicular Nerve Blocks for ... Read More
U.S., Feb. 5 -- ClinicalTrials.gov registry received information related to the study (NCT06806995) titled 'A Single-center, Open-label, Study Evaluating Safety and Pharmacokinetics of Single Doses of... Read More
U.S., Feb. 5 -- ClinicalTrials.gov registry received information related to the study (NCT06807281) titled 'A Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older With... Read More